A second-generation antibody–drug conjugate to treat HER2-positive breast cancer. Issue 10371 (14th January 2023)

Record Type:: Journal Article
Title:: A second-generation antibody–drug conjugate to treat HER2-positive breast cancer. Issue 10371 (14th January 2023)
Main Title:: A second-generation antibody–drug conjugate to treat HER2-positive breast cancer
Authors:: Rassy, Elie
Delaloge, Suzette
Abstract:
Is Part Of:: Lancet. Volume 401:Issue 10371(2023)
Journal:: Lancet
Issue:: Volume 401:Issue 10371(2023)
Issue Display:: Volume 401, Issue 10371 (2023)
Year:: 2023
Volume:: 401
Issue:: 10371
Issue Sort Value:: 2023-0401-10371-0000
Page Start:: 80
Page End:: 81
Publication Date:: 2023-01-14
Subjects:: Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5
Journal URLs:: http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0140-6736(22)02534-X ↗
Languages:: English
ISSNs:: 0140-6736
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25140.xml